High field MRI in preclinical research

European Journal of Radiology

Volumn 48, Issue 2, 2003, Pages 165-170

  Marzola, Pasquina ^a   Osculati, Francesco ^a   Sbarbati, Andrea ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Contrast agents; fMRI; Molecular imaging; MR microscopy; MRS; Pharmacological MRI

Indexed keywords

MAGNETIC RESONANCE SPECTROSCOPY; SIGNAL TO NOISE RATIO; SPECTROSCOPY; TISSUE;

CHEMICAL SHIFT;

MAGNETIC RESONANCE IMAGING;

BETA GALACTOSIDASE; CONTRAST MEDIUM;

BRAIN TUMOR; COST BENEFIT ANALYSIS; DIFFUSION WEIGHTED IMAGING; ELECTRONICS; HUMAN; IN VIVO STUDY; MAGNET; MAGNETIC FIELD; METABOLITE; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL RESOLUTION; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SIGNAL NOISE RATIO; SPECTRAL SENSITIVITY; SPECTROSCOPY; TECHNIQUE;

EID: 0242438608     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2003.08.007     Document Type: Article

References (47)

1. Beckmann N., Mueggler T., Allegrini P.R., Laurent D., Rudin M. From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat. Rec. 265:(2):2001;85-100.
2. Bremer C., Weissleder R. In vivo imaging of gene expression. Acad. Radiol. 8:(1):2001;15-23.
3. Marzola P., Farace P., Calderan L., et al. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int. J. Cancer. 104:(4):2003;462-468.
4. Baumann D., Rudin M. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn. Reson. Imaging. 18:(5):2000;587-595.
5. Lunati E., Farace P., Nicolato E., et al. Polyunsaturated fatty acids mapping by (1)H MR-chemical shift imaging. Magn. Reson. Med. 46:2001;879-883.
6. Bottomly P.A., Andrew E.R. RF magnetic field penetration, phase shift and power dissipation in biological tissue: implication for NMR imaging. Phys. Med. Biol. 23:1978;630-643.
7. Hoult D.I., Lauterbur P.C. The sensitivity of the zeugmatographic experiment involving human samples. J. Magn. Reson. 34:1979;425-433.
8. Hoult D.I., Phil D. Sensitivity and power deposition in a high-field imaging experiment. J. Magn. Reson. Imaging. 12:2000;46-67.
9. Anonymous. Special Issue on MR Safety, J Magn Reson Imaging 2000;12:1-204.
10. Schenck J.F. Safety of strong, static magnetic fields. J. Magn. Reson. Imaging. 12:2000;3-19.
11. Schaefer D.J., Bourland J.D., Nyenhuis J.A. Review of patient safety in time-varying gradients fields. J. Magn. Reson. Imaging. 12:2000;20-29.
12. Mansfield P., Morris P.G. NMR imaging in biomedicine. Advances in magnetic resonance. Supplement 2. 1982;Academic Press, New York.
13. Callaghan P.T. Principles of nuclear magnetic resonance microscopy. 1993;Clarendon Press, Oxford.
14. Blackband S.J., Buckley D.L., Bui J.D., Phillips M.I. NMR microscopy-beginning and new directions. Magn. Reson. Mat. Phys. Biol. Med. 9:1999;112-116.
15. Aguayo J.B., Blackband S.J., Schoeniger J., Mattingly M.A., Hintermann M. Nuclear magnetic resonance imaging of a single cell. Nature. 322:(6075):1986;190-191.
16. Bowtell R.W., Peters A., Sharp J.C., et al. NMR microscopy of single neurons using spin echo and line narrowed 2DFT imaging. Magn. Reson. Med. 33:(6):1995;790-794.
17. Blackband S.J., Bui J.D., Buckley D.L., et al. MR microscopy of perfused brain slices. Magn. Reson. Med. 38:(6):1997;1012-1015.
18. Johnson G.A., Cofer G.P., Gewalt S.L., Hedlund L.W. Morphologic phenotyping with MR microscopy: the visible mouse. Radiology. 222:2002;789-793.
19. Ogawa S., Lee T.M., Kay A.R., Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA. 87:(24):1990;9868-9872.
20. Logothetis N.K., Pauls J., Augath M., Trinath T., Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 412:(6843):2001;150-157.
21. Yacoub E., Shmuel A., Pfeuffer J., et al. Imaging brain function in humans at 7 T. Magn. Reson. Med. 45:2001;588-594.
22. Duong T.Q., Yacoub E., Adriany G., Hu X., Ugurbil K., Kim S.G. Microvascular BOLD contribution at 4 and 7 T in the human brain: gradient-echo and spin-echo fMRI with suppression of blood effects. Magn. Reson. Med. 49:2003;1019-1027.
23. Gyngell M.L., Bock C., Schmitz B., Hoehn-Berlage M., Hossmann K.A. Variation of functional MRI signal in response to frequency of somatosensory stimulation in a-chloralose anestetized rats. Magn. Reson. Med. 36:1996;13-15.
24. Yang X., Renken R., Hyder F., Siddeek M., Greer C.A., Shepherd G.M., Shulman R.G. Dynamic mapping at the laminar level of odor-elicited responses in rat olfactory bulb by functional MRI. Proc. Natl. Acad. Sci. USA. 95:(13):1998;7715-7720.
25. Bock C., Schmitz B., Kerskens C.M., Gyngell M.L., Hossmann K.A., Hoehn-Berlage M. Functional MRI of somatosensory activation in rat: effect of hypercapnic upregulation on perfusion- and BOLD-imaging. Magn. Reson. Med. 39:1998;457-461.
26. Silva A.C., Lee S.P., Iadecola C., Kim S.G. Early temporal characteristics of cerebral blood flow and deoxyhemoglobin changes during somatosensory stimulation. J. Cereb. Blood Flow Metab. 20:(1):2000;201-206.
27. Xu F., Kida I., Hyder F., Shulman R.G. Assessment and discrimination of odours stimuli in rat olfactory bulb by dynamic functional MRI. Proc. Natl. Acad. Sci. USA. 97:(19):2000;10601-10606.
28. Belliveau J.W., Kennedy D.N. Jr, McKinstry R.C., et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 254:(5032):1991;716-719.
29. Mandeville J.B., Marota J.J., Kosofsky B.E., et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 39:(4):1998;615-624.
30. van Bruggen N., Busch E., Palmer J.T., Williams S.P., de Crespigny A.J. High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media. J. Cereb. Blood Flow Metab. 18:(11):1998;1178-1183.
31. Palmer J.T., de Crespigny A.J., Williams S., Busch E., van Bruggen N. High-resolution mapping of discrete representational areas in rat somatosensory cortex using blood volume-dependent functional MRI. Neuroimage. 9:(4):1999;383-392.
32. Marota J.J., Mandeville J.B., Weisskoff R.M., Moskowitz M.A., Rosen B.R., Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. Neuroimage. 11:(1):2000;13-23.
33. Reese T., Bjelke B., Porszasz R., et al. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed. 13:2000;43-49.
34. Fabene P., Marzola P., Sbarbati A., Bentivoglio M. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage. 18:(2):2003;375-389.
35. Sbarbati A., Reggiani A., Lunati E., et al. Regional cerebral blood volume mapping after ischemic lesions. Neuroimage. 12:(4):2000;418-424.
36. Reese T., Porszasz R., Baumann D., et al. Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI. NMR Biomed. 13:(6):2000;361-370.
37. Dijkhuizen R.M., Ren J., Mandeville J.B., et al. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc. Natl. Acad. Sci. USA. 98:(22):2001;12766-12771.
38. Hakumaki J.M., Poptani H., Puumalainen A.M., et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res. 58:1998;3791-3799.
39. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat. Med. 5:(11):1999;1323-1327.
40. Nicolay K., Braun K.P., Graaf R.A., Dijkhuizen R.M., Kruiskamp M.J. Diffusion NMR spectroscopy. NMR Biomed. 14:(2):2001;94-111.
41. Mori S., van Zijl P.C. Fiber tracking: principles and strategies-a technical review. NMR Biomed. 15:(7-8):2002;468-480.
42. Chang K.H., Ra D.G., Han M.H., Cha S.H., Kim H.D., Han M.C. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. Am. J. Neuroradiol. 15:(8):1994;1413-1419.
43. Uematsu H., Dougherty L., Takahashi M., et al. A direct comparison of signal behaviour between 4.0 and 1.5 T: a phantom study. Eur. J. Radiol. 45:(2):2003;154-159.
44. Elster A.D. Field-strength dependence of gadolinium enhancement: theory and implications. Am. J. Neuroradiol. 15:1994;1420-1423.
45. Louie A.Y., Huber M.M., Ahrens E.T., et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:2000;321-325.
46. Asperio R.M., Nicolato E., Marzola P., et al. Delayed muscle injuries in arterial insufficiency: contrast-enhanced MR imaging and 31P spectroscopy in rats. Radiology. 220:(2):2001;413-419.
47. Sbarbati A., Osculati F. Tissutal imaging by nuclear magnetic resonance. Histol. Histopathol. 11:1996;229-235.